Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure
Tomoaki Uemura(Kumamoto University), Hisao Ogawa(Kumamoto University Hospital), Kenji Sakamoto(Kumamoto University), Yasuyuki Yamashita(Kumamoto University), Daisuke Utsunomiya(Yokohama City University), Seiji Takashio(Kumamoto University), Seiji Hokimoto(Kumamoto University), Sunao Kojima(Kumamoto University), Koichi Kaikita(Kumamoto University), Kyoko Hirakawa(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Eiichiro Yamamoto(Sapporo Medical University), Kenichi Tsujita(Kumamoto University)
Cited by 6
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755